Editorial Commentary
Online First
The articles on this page have been copyedited and reviewed and approved by the authors. They have not yet been scheduled for a specific issue. For published content, please visit Archive.
Editorial Commentary
Reframing the immunotherapy landscape in borderline resectable pancreatic ductal adenocarcinoma: progress or plateau?
Editorial Commentary
Cachexia, cytokines, and caution: lessons from tocilizumab in advanced pancreatic ductal adenocarcinoma
Editorial Commentary